The Pharma Data

DECEMBER 3, 2020

The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e.,

Treatment 52

Treatment Pharmaceutical Companies Therapies Virus 52

Drug Discovery World

MAY 28, 2023

1 Clinical trials Until recently, medicines and vaccines were mainly tested on men. They know that male and female bodies are genetically different, that they experience differences in the prevalence, course and severity of many common human diseases and metabolise foreign substances – like medicines and vaccines – differently.

International 130

International Vaccine Nurses Drugs 130

PLOS: DNA Science

MARCH 30, 2023

. “What is different and particularly scary about Candida auris is that it can survive on skin and healthcare surfaces up to two weeks, allowing the spread from person-to-person in healthcare settings and nursing homes. The lineages comprising evolutionary trees, from people to viruses, are called phylogenies.

DNA 52

DNA Hospitals Laboratories Virus 52

The Pharma Data

MAY 13, 2021

You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. 2009 Jun;139(6):1242S-1245S. A survey of the opinions of obesity experts on the causes and treatment of obesity. 2009 Oct;23(7):2090-5. 2009 Dec;34(13):2767-78.

Disease 52

Disease Production Testimonials Science 52